Are stem cell and exosome treatments FDA-approved?
No. Neither exosomes nor MSC therapies are FDA-approved for orthopedic, neurologic, or anti-aging use. They are considered investigational. We use products from vetted U.S. labs, and we discuss the state of the evidence honestly at your consultation.
Is this covered by insurance?
No. Regenerative therapies are cash-pay wellness services. HSA and FSA accounts are sometimes eligible — check with your plan. See our Billing page for details.
How is this different from PRP?
Platelet-rich plasma (PRP) uses your own blood-derived growth factors. Exosome and MSC therapies use externally-sourced products that carry more concentrated and diverse repair signals. Both have a role. PRP is often the right first step; regenerative products are typically considered when PRP and conservative care have plateaued.
How many sessions will I need?
It depends on the target. Joint protocols are typically 1–3 sessions spaced weeks apart. IV protocols vary. We build a plan tailored to your case, not a package.
What are the risks?
Reported risks in published studies are low but not zero — most commonly transient injection-site pain or inflammation. Because these products are investigational, longer-term risks are not fully characterized. We review individual risk with you at consultation.
Can you combine this with ozone or peptide therapy?
Yes — and we often do. Ozone, IV nutrient support, and select peptides can be paired thoughtfully to amplify recovery signals. See our Weight Loss & Peptides page for the recovery-focused version.